SuperworthAdial Pharmaceuticals shares outstanding ADIL
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 4.6M
- On a year earlier
- +987.7%
- more shares
Adial Pharmaceuticals had 4.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 987.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 1.1M | +325% |
| FY2024 | 256.2K | +175% |
| FY2023 | 93K | +126% |
| FY2022 | 41.2K | +24% |
| FY2021 | 33.2K | +44% |
| FY2020 | 23K | +35% |
| FY2019 | 17K | +60% |
| FY2018 | 10.6K | +103% |
| FY2017 | 5.2K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 4.6M | +988% | |
| Q1 FY26 | 1.4M | +424% | |
| Q4 FY25 | 1.1M | +325% | |
| Q3 FY25 | 886.9K | +280% | |
| Q2 FY25 | 424.9K | +154% | |
| Q1 FY25 | 261.6K | +121% | |
| Q4 FY24 | 256.2K | +175% | |
| Q3 FY24 | 233.4K | +395% | |
| Q2 FY24 | 167.3K | +270% | |
| Q1 FY24 | 118.2K | +179% | |
| Q4 FY23 | 93K | +126% | |
| Q3 FY23 | 47.1K | +15% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Adial Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.